Clinical Trial: A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time

U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839884) titled 'A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time' on Sept. 18.

Brief Summary: A Continuation Study of Tilrekimig in Adults with Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About this Medicine when Used for a Long Period of Time.

Study Start Date: Sept. 21

Study Type: INTERVENTIONAL

Condition: Moderate to Severe Chronic Obstructive Pulmonary Disease

In...